RMD Filing
4Filing Date: Mar 3, 2026
RESMED INC (RMD) · Insider Trading (Form 4) SEC Filing
Statement of Changes in Beneficial Ownership
descriptionView SEC Filing
ACC: 0000943819-26-000013open_in_new
Total Value$254.3K
Trades1
Insiders1
Transaction Details
Sandercock Brett
Chief Financial Officer·Direct
Sell · Dispose
ResMed Common Stock
Shares-1.00K
Price$254.30
Total Value$254.3K
Shares Owned After84.50K
Transaction DateMar 2, 2026
10b5-1
Footnotes ▸
The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
Post-Transaction Holdings
Sandercock Brett
| Security | Shares | Change |
|---|---|---|
| ResMed Common Stock | 84.50K | -1.00K (-1.17%) |
Original SEC Filing Textexpand_more
=== SEC Form 4 — Statement of Changes in Beneficial Ownership ===
Document Type: 4
Period of Report: 2026-03-02
10b5-1 Pre-arranged Plan: Yes
--- Issuer ---
Name: RESMED INC (RMD)
CIK: 0000943819
--- Reporting Owner ---
Name: Sandercock Brett
CIK: 0001346064
Role: Officer (Chief Financial Officer)
--- Non-Derivative Transactions ---
[Transaction #1]
Security: ResMed Common Stock
Date: 2026-03-02 | Code: S (Open market sale)
Shares: -1,000 | Price: $254.30
Total Value: $254,300.00
Shares Owned After: 84,495 | Ownership: D (Direct)
Footnotes:
[F1] The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
--- Footnotes (Complete Index) ---
F1: The transaction was conducted under a Rule 10b5-1 plan adopted February 19, 2025.
--- Signature ---
/s/ /s/ Brett Sandercock, Chief Financial Officer (2026-03-03)